Table 2 Aspirin Screening and Recommendations for Pre- and Post-intervention Cohorts, by Self-identified Black or Non-Black Race
Characteristic or Outcome, n (%) | Pre-intervention (n = 201) | Post-intervention (n = 199) | Exact p-value |
|---|---|---|---|
Patients | |||
Black | 24 (11.9) | 27 (13.6) | 0.655* |
Non-Black | 177 (88.1) | 172 (86.4) | 0.655* |
Screened for aspirin | N/A | 197 (99.0) | |
Black | N/A | 26 (96.3) | 0.254** |
Non-Black | N/A | 171 (99.4) | |
Candidates for aspirin | 94 (46.8) | 95 (47.7) | 0.920* |
Black | 21 (87.5) | 25 (92.6) | < 0.001** |
Non-Black | 73 (41.2) | 70 (40.7) | |
Correct recommendation for aspirin | 26 (27.7) | 75 (78.9) | < 0.001* |
Black | 6 (28.6) | 20 (80.0) | 1.000** |
Non-Black | 20 (27.4) | 55 (78.6) | |
Incorrect recommendation for aspirin | 5 (4.7) | 11 (10.6) | 0.124* |
Black | 0 (0.0) | 0 (0.0) | 1.000** |
Non-Black | 5 (4.8) | 11 (10.8) |